Original Research

Page 19

Recently published articles about Original Research

PCC
Association of Khat Use Disorder and Antisocial Personality Disorder Among Inmates
Original Research

October 17, 2023

This study examined the relationship between khat use disorder and antisocial personality disorder in newly admitted inmates in a correctional facility in Ethiopia.
, ,
JCP
Obsessive-Compulsive Symptoms and Psychosis Risk
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ October 16, 2023

Among youth at clinical high risk for psychosis, obsessive-compulsive symptoms had a high prevalence (50%) and were associated with a more severe clinical and functional profile.
, , , et al
JCP
Solriamfetol for ADHD in Adults
Original Research

October 9, 2023

Some individuals with attention-deficit/hyperactivity disorder (ADHD) may not tolerate or adequately respond to currently available treatments. This study examined the efficacy and tolerability of solriamfetol in the treatment for...
, , , et al
PCC
Post-COVID Lung Dysfunction and New-Onset Anxiety and Depression
Original Research

October 5, 2023

Incentive spirometry, in addition to providing gains in pulmonary function, improved new-onset anxiety and depressive symptoms in post-COVID patients.
, , , et al
JCP
Celecoxib Augmentation of Vortioxetine for Cognition in MDD
Original Research

October 4, 2023

Anti-inflammatory augmentation of vortioxetine did not provide additional benefit in reducing cognitive symptoms of MDD.
, , , et al
PCC
Psychiatric Comorbidities of Neurofibromatosis
Original Research

October 3, 2023

Neurofibromatosis is a group of inherited neurocutaneous disorders that includes neurofibromatosis types 1 and 2 and schwannomatosis. This study assessed the prevalence of psychiatric comorbidities in patients with neurofibromatosis.
, , , et al

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe